Biopharmaceutical Company Announces FDA Approval For MDS Treatment
Geron Announces FDA Approval of RYTELO™ (Imetelstat) for Lower-Risk MDS with Transfusion-Dependent Anemia.
Disclaimer: This article is intended for informational purposes only and should not be considered as medical advice. Consult a healthcare professional for medical advice and treatment options.
As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account…